From: Gail Clement <[log in to unmask]> Date: Mon, 21 Oct 2013 09:44:45 +0000 Here is the link to the paper on challenges in reproducing scientific findings, discussed in the keynote for the 2013 Peer Review Congress. (Sincere apologies for typos in my previous posting about this.) John P. A. Ioannidis , Why Most Published Research Findings Are False, PLos Medicine, 2(8): e124. doi:10.1371/journal.pmed.0020124 http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0020124 FYI, this excellent meeting focuses on ethical and quality issues in scientific (mostly biomed) publishing. Lots of evidence-based papers on various publishing issues. The venue is quadrennial --see you there in 2017? Gail Clement -----Original Message----- From: Ari Belenkiy <[log in to unmask]> Date: Sat, 19 Oct 2013 21:43:11 -0700 >> Last year researchers at one biotech firm, Amgen, found they could reproduce just six of 53 "landmark" studies in cancer research. Earlier, a group at Bayer, a drug company, managed to repeat just a quarter of 67 similarly important papers. Does anyone know the details of these results? Ari Belenkiy SFU Canada